Human Lysozyme Monoclonal Antibody

Biomedical Technologies Inc

BTI Lysozyme monoclonal antibody is produced in Balb/c mice using Human Lysozyme (purified from human urine) as immunogen. Hybridomas were generated after fusion of immune spleen cells with P3xAg8.653 myeloma cells. The resulting antibody is an IgG1 kappa.

This antibody reacts with Human Lysozyme by ELISA (1:200,000) and by WB (1:20).

Please call for spec sheet.


Shipping Standard

Buy now


Please contact us for pricing BT-577

All prices shown are exclusive of VAT